ctrl+s GmbH | $1,083,350 | (Mar 7, 2025)
Medly AI | $2,194,785 | (Mar 7, 2025)
hema.to GmbH | $3,900,060 | (Mar 7, 2025)
Certified by Founder
Lodge
AvenCell
start up
United States
- Cambridge, Massachusetts
- 22/10/2024
- Series B
- $112,000,000
Based on our deep science and focused on patients in need, we develop next generation immunotherapies for hard-to-treat cancers.
- Industry Biotechnology
- Website https://avencell.com/
- LinkedIn https://www.linkedin.com/company/avencell/
Tiga AI | $2,000,000 | (Mar 7, 2025)
Lumata Health | $20,000,000 | (Mar 7, 2025)
CaPow | $15,000,000 | (Mar 7, 2025)
Uniti AI | $4,000,000 | (Mar 7, 2025)
WilsonAI | $1,700,000 | (Mar 7, 2025)
Epirus | $250,000,000 | (Mar 7, 2025)
Numeral(US) | $18,000,000 | (Mar 7, 2025)
Telescope(NORWAY) | $4,000,000 | (Mar 7, 2025)
TRIMTECH Therapeutics Limited | $31,000,000 | (Mar 7, 2025)
Intangible | $4,000,000 | (Mar 7, 2025)